-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SR-604 in Hemophilia A (Factor VIII Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SR-604 in Hemophilia A (Factor VIII Deficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SR-604 in Hemophilia A (Factor VIII Deficiency) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axitinib SR in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axitinib SR in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axitinib SR in Wet (Neovascular /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axitinib SR in Non-Proliferative Diabetic Retinopathy (NPDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axitinib SR in Non-Proliferative Diabetic Retinopathy (NPDR) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axitinib SR in Non-Proliferative Diabetic Retinopathy (NPDR) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Centanafadine SR in Attention Deficit Hyperactivity Disorder (ADHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Centanafadine SR in Attention Deficit Hyperactivity Disorder (ADHD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Centanafadine SR in Attention Deficit Hyperactivity Disorder...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SR-604 in Hemophilia B (Factor IX Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SR-604 in Hemophilia B (Factor IX Deficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SR-604 in Hemophilia B (Factor IX Deficiency) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Treprostinil SR in Raynauds Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Treprostinil SR in Raynauds Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Treprostinil SR in Raynauds Disease Drug Details: Treprostinil(CAM-2043) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fluocinolone Acetonide SR in Posterior Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fluocinolone Acetonide SR in Posterior Uveitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fluocinolone Acetonide SR in Posterior Uveitis Drug Details: Fluocinolone acetonide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Treprostinil SR in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Treprostinil SR in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Treprostinil SR in Pulmonary Arterial Hypertension Drug Details: Treprostinil(CAM-2043) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Centanafadine SR in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Centanafadine SR in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Centanafadine SR in Major Depressive Disorder Drug Details: Centanafadine SR...